| |
|
|
|
|
|
|
|||
|
Blood, 1 June 2005, Vol. 105, No. 11, pp. 4207-4214. Prepublished online as a Blood First Edition Paper on February 15, 2005; DOI 10.1182/blood-2004-07-2697.
Submitted July 15, 2004
Center for Cancer Research (CCR) Laboratory of Molecular Immunoregulation (LMI), National Cancer Institute, Frederick, MD, USA * Corresponding author; email: howardz{at}mail.ncifcrf.gov.
We tested the hypothesis that interaction between autoantigens and chemoattractant receptors may be an important step in the development of autoimmunity. The retinal autoantigens S-Antigen (S-Ag), and interphotoreceptor retinoid binding protein (IRBP) can induce autoimmune uveitis in rodent models. We evaluated the chemotactic activity of S-Ag and IRBP and found that both induced migration of human and mouse immature dendritic cells (iDCs) and lymphocytes, but not neutrophils, monocytes or mature DCs. Cross desensitization studies and single-receptor transfected cells revealed that CXCR5 and CXCR3 mediated the chemotactic effect of IRBP, while only CXCR3 was required for the chemotactic response to S-Ag. Examination of the relationships between chemoattraction and the ability to elicit pathology at the protein or peptide levels in the mouse uveitis model revealed dissociation of the capacity to induce uveitis, lymphocyte proliferation, and chemoattraction. These studies suggest that IRBP and S-Ag can initiate innate and, in sensitive individuals, adaptive immune response by attracting iDCs, T- and B-cells expressing CXCR3 and CXCR5.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2005 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||